Trial
NCT04619420
A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Janssen Research & Development, LLC
Collaborators
—
Condition
Alzheimer Disease
Intervention
JNJ-63733657
Why stopped
Posdinemab did not achieve statistical significance in slowing clinical decline
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-03